RAY OLSON: Open Payments
NPI 1033776562 · NORTH LOGAN, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$614 in 30 payments from 10 companies in 2025. Trend: 2023 $709 · 2024 $753 · 2025 $614
Food & beverage: $546Education: $68
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 8 | $144 |
| Regeneron Healthcare Solutions, Inc. | 5 | $129 |
| Amgen Inc. | 5 | $79 |
| SANOFI-AVENTIS U.S. LLC | 1 | $68 |
| AstraZeneca Pharmaceuticals LP | 4 | $67 |
| Novartis Pharmaceuticals Corporation | 2 | $45 |
| GlaxoSmithKline, LLC. | 2 | $34 |
| ABBVIE INC. | 1 | $20 |
| Acella Pharmaceuticals, LLC | 1 | $16 |
| Merit Medical Systems Inc | 1 | $12 |
Products named: DUPIXENT, TEZSPIRE, TAVNEOS, TRELEGY ELLIPTA, FASENRA, QULIPTA, NP Thyroid 60, ESOPHYX.
Industry payments across UT — which companies pay providers there.
